Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild Moderate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00503243
What this trial is testing

Safety and Efficacy of SPD476 (Mesalazine) Given Twice Daily (2.4 g/Day) vs SPD476 Given as a Single Dose (4.8 g/Day) in Subjects With Acute Mild to Moderate Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Shire 280
Not applicableLooking for participantsNCT06813235
What this trial is testing

Dream2Heal: An Adaptive Stepped-care Intervention for Chinese Cancer Survivors With Mild-to-moderate Insomnia

Who this might be right for
NeoplasmSleep Disturbance
The University of Hong Kong 72
Testing effectiveness (Phase 2)Study completedNCT01657110
What this trial is testing

Pilot Study to Evaluate Tea Tree Oil Gel for Facial Acne

Who this might be right for
Acne
The University of Western Australia 18
Testing effectiveness (Phase 2)Ended earlyNCT04936113
What this trial is testing

Continued Safety Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis Previously Enrolled in the FB401-01 Study

Who this might be right for
Atopic Dermatitis
Forte Biosciences, Inc. 36
Early research (Phase 1)Study completedNCT00495417
What this trial is testing

Tolerability and Safety of Subcutaneous Administration of Affitope AD01 in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Affiris AG 24
Testing effectiveness (Phase 2)Study completedNCT00710684
What this trial is testing

SB-742457, Added to Donepezil for the Treatment of Mild-to-moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 682
Not applicableStudy completedNCT04544904
What this trial is testing

The Technology, Exercise Programming, and Activity Prescription for Enhanced Mobility (TEAM) Study

Who this might be right for
Osteo Arthritis KneeOsteoarthritisHip Arthritis
Western University, Canada 356
Not applicableStudy completedNCT01478204
What this trial is testing

Evaluate Sleep Quality in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Janssen-Cilag, S.A. 925
Testing effectiveness (Phase 2)Study completedNCT01281306
What this trial is testing

An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension

Who this might be right for
Systolic Hypertension
Novartis Pharmaceuticals 910
Post-approval studies (Phase 4)Study completedNCT00912171
What this trial is testing

Efficacy of Oral Leukotriene in Long Term Therapy of Mild and Moderate Obstructive Sleep Apnea Syndrome in Children

Who this might be right for
Obstructive Sleep Apnea Syndrome
University of Bologna 45
Testing effectiveness (Phase 2)Study completedNCT04551898
What this trial is testing

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)

Who this might be right for
Covid19
BeiGene 181
Early research (Phase 1)Ended earlyNCT00457171
What this trial is testing

GI-270384 Study In Patients With Mild To Moderate Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
GlaxoSmithKline 16
Early research (Phase 1)Looking for participantsNCT06376474
What this trial is testing

To Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Liver Damage

Who this might be right for
Psoriasis
Ganzhou Hemay Pharmaceutical Co., Ltd 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT04257578
What this trial is testing

Acalabrutinib and Anti-CD19 CAR T-cell Therapy for the Treatment of B-cell Lymphoma

Who this might be right for
B-Cell Non-Hodgkin LymphomaDiffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedHigh Grade B-Cell Lymphoma+5 more
University of Washington 23
Post-approval studies (Phase 4)Study completedNCT01951417
What this trial is testing

Adapalene BPO Gel Pump, Moisturizer SPF 30 and Foam Wash in Patients With Mild to Moderate Acne Vulgaris

Who this might be right for
Acne
Galderma R&D 81
Large-scale testing (Phase 3)Looking for participantsNCT04435990
What this trial is testing

Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites

Who this might be right for
Rhinitis, AllergicRhinoconjunctivitisAsthma, Allergic
Inmunotek S.L. 150
Early research (Phase 1)Study completedNCT01558323
What this trial is testing

Pharmacokinetics of LCQ908 in Patients With Renal Impairment

Who this might be right for
Renal Impairment
Novartis Pharmaceuticals 58
Early research (Phase 1)Study completedNCT01054261
What this trial is testing

To Compare the Pharmacokinetics of Avanafil in Subjects With Mild and Moderate Renal Impairment to Subjects With Normal Renal Function.

Who this might be right for
Renal
VIVUS LLC 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07382427
What this trial is testing

Assess the Effectiveness of Topical Terbinafine in Participants With Mild to Moderate Onychomycosis of the Toenails

Who this might be right for
Onychomycosis of Toenail
Onyx Axiom 200
Testing effectiveness (Phase 2)Study completedNCT05276323
What this trial is testing

Medihoney® Derma Cream Treatment for Mild to Moderate Atopic Dermatitis in Children Study

Who this might be right for
Atopic Dermatitis
Soroka University Medical Center 30
Next Page